Minor adverse events · sexually active adults
It is very uncertain whether macrolides changes minor adverse events compared with any other antibiotic (very low certainty).
1 finding from 1 review
Minor adverse events · sexually active adults
It is very uncertain whether macrolide (erythromycin) changes minor adverse events compared with any other macrolide (very low certainty).
1 finding from 1 review
Signs and symptoms of respiratory disease · Children with obstructive sleep apnoea (aged 15 years or younger)
The review found no eligible studies for this question.
1 finding from 1 review
Minor morbidity: total · women > 6 weeks postpartum requesting tubal sterilisation
Summary of findings: modified Pomeroy partial salpingectomy may leads to higher minor morbidity: total compared with electrocoagulation (low certainty).
1 finding from 1 review
Minor morbidity: procedure‐related injuries with no additional operation · women > 6 weeks postpartum requesting tubal sterilisation
Summary of findings: modified Pomeroy partial salpingectomy showed no clear difference in minor morbidity: procedure‐related injuries with no additional… compared with electrocoagulation (moderate certainty).
1 finding from 1 review
Minor morbidity: total · women > 6 weeks postpartum requesting tubal sterilisation
Summary of findings: tubal ring showed no clear difference in minor morbidity: total compared with electrocoagulation (moderate certainty).
1 finding from 1 review
Minor morbidity: total · women > 6 weeks postpartum requesting tubal sterilisation
Summary of findings: ring leads to higher minor morbidity: total compared with clip (high certainty).
1 finding from 1 review
Minor morbidity: total · women requesting postpartum or interval sterilisation
Summary of findings: partial salpingectomy showed no clear difference in minor morbidity: total compared with clip (low certainty).
1 finding from 1 review
Minor morbidity: total · women requesting sterilisation
Summary of findings: Hulka clip showed no clear difference in minor morbidity: total compared with filshie clip (low certainty).
1 finding from 1 review
Minor morbidity: details ‐ procedure‐related injuries · women requesting sterilisation
Summary of findings: Hulka clip showed no clear difference in minor morbidity: procedure‐related injuries compared with filshie clip (moderate certainty).
1 finding from 1 review
Minor morbidity: details ‐ procedure‐related injuries · women > 6 weeks postpartum requesting tubal sterilisation
Summary of findings: ring leads to higher minor morbidity: details ‐ procedure‐related injuries compared with clip (high certainty).
1 finding from 1 review
Minor haemorrhage · Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment
self‐management of oral anticoagulation showed no clear difference in minor haemorrhage compared with standard care (low certainty).
1 finding from 1 review
Minor haemorrhage · Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment
Self‐monitoring or self‐management of oral anticoagulation showed no clear difference in minor haemorrhage compared with standard care (low certainty).
1 finding from 1 review
Minor haemorrhage · Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment
Self‐monitoring of oral anticoagulation showed no clear difference in minor haemorrhage compared with standard care (moderate certainty).
1 finding from 1 review
Minor bleeding · people requiring prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor bleeding · people requiring prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
DOAC showed no clear difference in bleeding ‐ minor Treatment duration 28 ‐ 42 days compared with placebo (moderate certainty).
1 finding from 1 review
Minor bleeding · people requiring prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor bleeding · people requiring prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Vitamin K antagonists showed no clear difference in bleeding ‐ minor Treatment duration 28 ‐ 42 days compared with heparin (low certainty).
1 finding from 1 review
Minor bleeding · people requiring prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
DOAC showed no clear difference in bleeding ‐ minor Treatment duration 28 ‐ 42 days compared with heparin (high certainty).
1 finding from 1 review
Minor bleeding · people requiring prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Heparin leads to higher bleeding ‐ minor Treatment duration 28 ‐ 42 days compared with placebo (high certainty).
1 finding from 1 review